Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Folate supplements beneficial while doubts grow about fiber

Folate may inhibit the development of colorectal cancer—but fiber may not be as beneficial as was thought, according to two separate reports today.

News image

fiogf49gjkf04

Epidemiological studies over the past ten years have found a link between the regular consumption of dietary folate and the decreased development of colorectal cancer, the conference of the American College of Nutrition was told.

Dr Joel Mason, of Tufts University, Boston, Massachusetts, US, told delegates of new theories about why folate might be beneficial.

He said folate was critical in biochemical reactions where the carbon compound methyl group was added to large macromolecules such as DNA, and the synthesis of nucleotides.

Dr Mason told the conference in Las Vegas, US, that cancer was believed to arise from the result of unrepaired damage to DNA. An inadequate availability of folate could lead to interference with DNA synthesis requiring the methylation process.

He said research had found that a folate variant containing reductase enzyme, which is present in about 10% of people, had a protective effect on the development of colorectal cancers.

Dr Mason said randomized clinical trials were being conducted to determine whether folic acid supplement could protect against the development of precancerous polyps.

He said that folic acid was included in cereal grain flours to help prevent neural tube defects, spina bifida and brain development problems. But it still remained a marginal nutrient in the American diet.

"Only twenty percent of Americans consume the minimal five servings per day of folate-rich fruits and vegetables."

Dr Joel Mason

"Only twenty percent of Americans consume the minimal five servings per day of folate-rich fruits and vegetables," he told the conference.

"For example, fast food meals do not provide a single serving of salad food ingredients. Folate-rich citrus juices are consumed by only 25% of Americans on a given day."

Meanwhile in The Lancet, researchers report a link between dietary fiber supplements and an increased rate of colorectal adenomas.

The multicenter randomized trial from nine European countries and Israel tested the effect of diet supplementation with calcium and fiber. 665 patients with a history of adenomas were assigned to take a calcium supplement, ispaghula husk or placebos.

Follow-up found at least one adenoma in 16% of the calcium group, 20% in the placebo group and 29% among those taking the fiber.

Researcher Claire Bonithon-Kopp, of the European Cancer Prevention Organisation Study Group, Dijon, France, said: "Our study, along with the two American trials, suggests that low-fat, high-fiber diet and supplementation with wheat-bran fiber or ispaghula husk may not be effective strategies for the prevention of colorectal adenoma recurrence.

"However, our findings should not prevent recommendations for high consumption of vegetables, fruits, and cereals, because this approach has potentially beneficial effects on other chronic diseases."

Report Copyright: Englemed Health News at http://www.internationalmedicalnews.com

Lancet October 14 2000
13 October 2000

Go to top of page Email this page Email this page to a colleague

 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 20 October 2017 
Hospital readmissions reduction program
 19 October 2017 
Surgical anastomosis at 1-year colorectal cancer surveillance
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us